Asia-Pacific human leukocyte antigen (HLA) typing for transplant market is growing with a CAGR of 8.4% in the forecast period of 2021 to 2028 and is expected to reach USD 240.14 million by 2028 from USD 129.52 million in 2020
Asia-Pacific Human Leukocyte Antigen (HLA) Typing for Transplant Market, By Products and Services (Reagents and Consumables, Instruments, Software and Services), Technology (Sequencing- Based Molecular Assays, Molecular Assay Technologies, Non- Molecular Assay Technologies), Transplant Type (Solid Organ Transplant, Haematopoietic Stem Cell Transplant), Application (Diagnostic Applications, Research Application), End User (Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes), Country (China, India, Japan, South Korea, Australia, Thailand, Malaysia, Philippines, Singapore, Indonesia, and Rest of Asia-Pacific) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Asia-Pacific Human Leukocyte Antigen (HLA) Typing for Transplant Market
-
· Asia-Pacific human leukocyte antigen (HLA) typing for transplant market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the Asia-Pacific human leukocyte antigen (HLA) typing for transplant market is growing with a CAGR of 8.4% in the forecast period of 2021 to 2028 and is expected to reach USD 240.14 million by 2028 from USD 129.52 million in 2020. Rising demand for organ transplant procedures is acting as driver for the growth of the human leukocyte typing for transplant market.
-
· Human leukocyte antigen (HLA) typing is used to match patients and donors for bone marrow or cord blood transplants. HLA are proteins -- or markers -- found on most cells in the body. The immune system uses these markers to recognize which cells belong to the body and which do not.
Asia-Pacific Human Leukocyte Antigen (HLA) Typing for Transplant Market and Market Size
-
· On the basis of by products and services, Asia-Pacific human leukocyte antigen (HLA) typing for transplant market is segmented in reagents and consumables, instruments, software and services. In 2021, instruments segment is expected to dominate the market due to rising healthcare expenditure.
-
· On the basis of technology, Asia-Pacific human leukocyte antigen (HLA) typing for transplant market is molecular assay technologies and non- molecular assay technologies. In 2021, molecular assay technologies segment is expected to dominate the market because of the rising success and greater improvement in post-transplant outcome.
-
· On the basis of transplant type, Asia-Pacific human leukocyte antigen (HLA) typing for transplant market is segmented solid organ transplant and haematopoietic stem cell transplant. In 2021, solid organ transplant segment is expected to dominate the market due to better patient compliance.
-
· On the basis of application, the Asia-Pacific human leukocyte antigen (HLA) typing for transplant market is segmented into diagnostic applications and research application. In 2021, diagnostic applications segment is expected to dominate the market because of the increased incidence of vital organ failure, doctors tend to detect problem prior via diagnostic applications.
-
· On the basis of end user, the Asia-Pacific human leukocyte antigen (HLA) typing for transplant market is segmented into independent reference laboratories, hospitals and transplant centres, research laboratories and academic institutes. In 2021, hospitals & transplant centers segment is expected to dominate the market owing to increased government funding.
Get the sample copy of Report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-hla-typing-transplant-market
Asia-Pacific Human Leukocyte Antigen (HLA) Typing for Transplant Market Country Level Analysis
-
· Countries covered in the Asia-Pacific human leukocyte antigen (HLA) typing for transplant market report are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and rest of Asia-Pacific.
Competitive Landscape and Asia-Pacific Human Leukocyte Antigen (HLA) Typing for Transplant Market Share Analysis
-
· Asia-Pacific human leukocyte antigen (HLA) typing for transplant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to Asia-Pacific human leukocyte antigen (HLA) typing for transplant market
Major players covered in the report are
-
· Thermo Fisher Scientific Inc
-
· Illumina, Inc
-
· Luminex Corporation
-
· QIAGEN, CareDX, Inc
-
· Immucor Inc
-
· Bio Rad Labaratories, Inc
-
· Takara Bio Inc.,
-
· BD, Fujirebio,
Full Access of Report @ https://www.databridgemarketresearch.com/reports/asia-pacific-hla-typing-transplant-market
MAJOR TOC OF THE REPORT
-
· INTRODUCTION
-
· MARKET SEGMENTATION
-
· EXECUTIVE SUMMARY
-
· PREMIUM INSIGHTS
-
· MARKET OVERVIEW
-
· QUESTIONNAIRE
· RELATED REPORTS
Get TOC Details
https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-hla-typing-transplant-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related Reports@
U.S. HLA Typing for Transplant Market – Industry Trends and Forecast to 2029
